ALX ONCOLOGY HOLDINGS INC (ALXO)
US00166B1052 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -166.20M | -160.81M | -123.48M | -83.46M | -45.74M | |||
| Depreciation Amortization | 840.00K | 836.00K | 340.00K | 50.00K | 200.00K | |||
| Change In Working Capital | 3.19M | 8.30M | 9.85M | -4.03M | 250.00K | |||
| Interest Paid | N/A | 1.18M | 100.00K | 10.00K | 430.00K | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 270.00K | 50.00K | |||
| Other non cash items | 21.71M | 21.31M | 24.07M | 19.34M | 7.00M | |||
| OPERATING CASH FLOW | -140.47M | -130.36M | -89.22M | -68.10M | -38.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -732.00K | -1.27M | -1.43M | -4.92M | -30.00K | |||
| Other Investing Activity | 29.56M | 45.93M | -233.99M | N/A | 640.00K | |||
| INVESTING CASH FLOW | 28.83M | 44.66M | -235.42M | -4.92M | 610.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -453.00K | -388.00K | 9.61M | -280.00K | 0.00 | |||
| Stock Issued/Repurchased | 1.03M | 792.00K | 900.00K | 2.75M | 473.24M | |||
| Other Financing Activity | N/A | 58.89M | -660.00K | N/A | -10.35M | |||
| FINANCING CASH FLOW | 62.49M | 59.29M | 9.86M | 2.47M | 462.88M | |||
| CHANGE IN CASH | -49.15M | -26.42M | -314.78M | -70.55M | 425.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -140.47M | -130.36M | -89.22M | -68.10M | -38.29M | |||
| Capital Expenditure | -732.00K | -1.27M | -1.43M | -4.92M | -30.00K | |||
| FREE CASH FLOW | -141.20M | -131.64M | -90.65M | -73.02M | -38.32M | |||
All data in USD